HCA

SEC source: 0001209191-23-012006 · doc4.xml · nonDerivative · entry 2

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,314

SEC source: 0001209191-23-012006 · doc4.xml · nonDerivative · entry 1

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,560

F1 · kind: On January 29, 2020, the reporting person was granted 2,280 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2020-2022. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2020-2022 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

SEC source: 0001209191-23-012005 · doc4.xml · nonDerivative · entry 2

Paslick P. Martin · CIK 0001551011 · SVP and CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,677

SEC source: 0001209191-23-012005 · doc4.xml · nonDerivative · entry 1

Paslick P. Martin · CIK 0001551011 · SVP and CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,266

F1 · kind: On January 29, 2020, the reporting person was granted 4,560 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2020-2022. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2020-2022 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

SEC source: 0001209191-23-012004 · doc4.xml · nonDerivative · entry 2

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,790

SEC source: 0001209191-23-012004 · doc4.xml · nonDerivative · entry 1

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,063

F1 · kind: On January 29, 2020, the reporting person was granted 560 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2020-2022. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2020-2022 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

SEC source: 0001209191-23-012003 · doc4.xml · nonDerivative · entry 2

McManus Timothy M · CIK 0001957740 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,149.4141

SEC source: 0001209191-23-012003 · doc4.xml · nonDerivative · entry 1

McManus Timothy M · CIK 0001957740 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,587.4141

F1 · kind: On January 29, 2020, the reporting person was granted 3,800 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2020-2022. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2020-2022 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

SEC source: 0001209191-23-012002 · doc4.xml · nonDerivative · entry 2

Marks Mike A · CIK 0001961124 · SVP-Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,593

SEC source: 0001209191-23-012002 · doc4.xml · nonDerivative · entry 1

Marks Mike A · CIK 0001961124 · SVP-Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,440

F1 · kind: On January 29, 2020, the reporting person was granted 3,040 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2020-2022. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2020-2022 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

SEC source: 0001209191-23-012000 · doc4.xml · nonDerivative · entry 2

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 163,787

SEC source: 0001209191-23-012000 · doc4.xml · nonDerivative · entry 1

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,557

F1 · kind: On January 29, 2020, the reporting person was granted 47,440 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2020-2022. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2020-2022 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

SEC source: 0001209191-23-011998 · doc4.xml · nonDerivative · entry 3

Hammett Richard A · CIK 0001957822 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,862

SEC source: 0001209191-23-011998 · doc4.xml · nonDerivative · entry 2

Hammett Richard A · CIK 0001957822 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,276

F2 · kind: On May 1, 2020, the reporting person was granted 3,810 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2020-2022. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2020-2022 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

SEC source: 0001209191-23-011998 · doc4.xml · nonDerivative · entry 1

Hammett Richard A · CIK 0001957822 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,656

F1 · kind: On January 29, 2020, the reporting person was granted 1,030 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2020-2022. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2020-2022 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

SEC source: 0001209191-23-011996 · doc4.xml · nonDerivative · entry 2

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,910

SEC source: 0001209191-23-011996 · doc4.xml · nonDerivative · entry 1

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,678

F1 · kind: On January 29, 2020, the reporting person was granted 9,870 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2020-2022. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2020-2022 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

SEC source: 0001209191-23-011993 · doc4.xml · nonDerivative · entry 2

Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,750.5543

SEC source: 0001209191-23-011993 · doc4.xml · nonDerivative · entry 1

Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,982.5543

F1 · kind: On January 29, 2020, the reporting person was granted 6,080 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2020-2022. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2020-2022 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

SEC source: 0001209191-23-011985 · doc4.xml · nonDerivative · entry 2

Cohen Jeffrey E. · CIK 0001790598 · SVP-Government Relations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,914

SEC source: 0001209191-23-011985 · doc4.xml · nonDerivative · entry 1

Cohen Jeffrey E. · CIK 0001790598 · SVP-Government Relations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,566

F1 · kind: On January 29, 2020, the reporting person was granted 2,280 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2020-2022. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2020-2022 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

SEC source: 0001209191-23-011977 · doc4.xml · nonDerivative · entry 2

Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,965.1056

SEC source: 0001209191-23-011977 · doc4.xml · nonDerivative · entry 1

Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,212.1056

F1 · kind: On January 29, 2020, the reporting person was granted 2,280 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2020-2022. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2020-2022 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

SEC source: 0001209191-23-011975 · doc4.xml · nonDerivative · entry 2

Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,551

SEC source: 0001209191-23-011975 · doc4.xml · nonDerivative · entry 1

Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,992

F1 · kind: On January 29, 2020, the reporting person was granted 3,800 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2020-2022. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2020-2022 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

SEC source: 0001209191-23-011970 · doc4.xml · nonDerivative · entry 2

Akdamar Erol R · CIK 0001957739 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,984

SEC source: 0001209191-23-011970 · doc4.xml · nonDerivative · entry 1

Akdamar Erol R · CIK 0001957739 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,094

F1 · kind: On January 29, 2020, the reporting person was granted 4,650 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2020-2022. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2020-2022 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

SEC source: 0001209191-23-011377 · doc4.xml · derivative · entry 3

Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,575 shares

Expires 2028-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.

SEC source: 0001209191-23-011377 · doc4.xml · nonDerivative · entry 2

Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,480

SEC source: 0001209191-23-011377 · doc4.xml · nonDerivative · entry 1

Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,947

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-23-008144 · doc4.xml · nonDerivative · entry 1

Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,392

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $255.2116 to $255.33, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-23-007165 · doc4.xml · nonDerivative · entry 4

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,632

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.67 to $258.54, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-23-007354 · doc4.xml · derivative · entry 5

Akdamar Erol R · CIK 0001957739 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,000 shares

Expires 2023-11-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on November 6, 2014.

SEC source: 0001209191-23-007354 · doc4.xml · nonDerivative · entry 3

Akdamar Erol R · CIK 0001957739 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,794

SEC source: 0001209191-23-007354 · doc4.xml · nonDerivative · entry 2

Akdamar Erol R · CIK 0001957739 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,726

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-23-007676 · doc4.xml · nonDerivative · entry 1

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.5901 to $257.78, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-23-007675 · doc4.xml · derivative · entry 3

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 275

Underlying: Common Stock · 138 shares

Expires 2031-02-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning February 3, 2022.

SEC source: 0001209191-23-007675 · doc4.xml · nonDerivative · entry 2

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,943

SEC source: 0001209191-23-007675 · doc4.xml · nonDerivative · entry 1

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,984

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001209191-23-007674 · doc4.xml · derivative · entry 5

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 59,000 shares

Expires 2025-02-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016.

SEC source: 0001209191-23-007674 · doc4.xml · nonDerivative · entry 2

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,677

SEC source: 0001209191-23-007674 · doc4.xml · nonDerivative · entry 1

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,885

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-23-007354 · doc4.xml · nonDerivative · entry 1

Akdamar Erol R · CIK 0001957739 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,726

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $258.62 to $258.718, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-23-006045 · doc4.xml · nonDerivative · entry 4

Wyatt Christopher F. · CIK 0001673365 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,392

SEC source: 0001209191-23-006044 · doc4.xml · nonDerivative · entry 3

Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,696

SEC source: 0001209191-23-006039 · doc4.xml · nonDerivative · entry 1

Paslick P. Martin · CIK 0001551011 · SVP and CIO

10b5-1 filing: Not disclosed

Ownership: Indirect · by 2021 Trust

Disclosed balance after: 3,000

SEC source: 0001209191-23-006032 · doc4.xml · nonDerivative · entry 4

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,938

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.10 to $252.08, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-23-006031 · doc4.xml · nonDerivative · entry 2

Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,822.5543

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.1031 to $257.285, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F1 · balance_after: Includes 2,330.5543 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.

SEC source: 0001209191-23-007165 · doc4.xml · derivative · entry 9

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,100

Underlying: Common Stock · 27,000 shares

Expires 2026-01-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017.

SEC source: 0001209191-23-007165 · doc4.xml · derivative · entry 8

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 37,000 shares

Expires 2025-02-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016.